StockData
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd (TLSA) shareholders

TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 1, 2026Score 3/30
$0.58+0.01 (+1.75%)

Close on Nov 16, 2026Market cap $69.89MP/E –Yield –

Ownership

Who owns Tiziana Life Sciences's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
5 buys · 0 sales
Net bought $1.04M

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Laura Natalia Monica Fonda6,805,5565.70%13G (passive)Sep 12, 2025
Chernett Jorey6,476,4715.40%13G (passive) amendmentSep 30, 2025

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ivor ElrifiChief Executive Officer9,648,9458.01%Sep 29, 2026
Keeren Rameshchandra ShahCHIEF OPERATING & FIN. OFFICER2,5000.00%May 22, 2026
Gabriele M. CerroneDirector, 10% owner89,469,41774.24%Aug 7, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ivor Elrifi
Chief Executive Officer
Aug 15, 2026Option exercise+1,050,000––5,843,684
Ivor Elrifi
Chief Executive Officer
Aug 5, 2026Buy+237,616$1.00$237.62K4,793,684
Ivor Elrifi
Chief Executive Officer
Aug 4, 2026Buy+83,807$0.97$81.29K4,556,068
Ivor Elrifi
Chief Executive Officer
Aug 3, 2026Buy+667,000$1.00$667.00K4,472,261
Gabriele M. Cerrone
Director, 10% owner
Jul 21, 2026Buy+42,357$0.99$41.93K44,814,587
Gabriele M. Cerrone
Director, 10% owner
Jul 21, 2026Award+42,357$0.99$41.93K44,814,587
Gabriele M. Cerrone
Director, 10% owner
Jun 12, 2026Buy+15,000$1.11$16.65K44,772,230
Gabriele M. Cerrone
Director, 10% owner
Jun 12, 2026Award+15,000$1.11$16.65K44,772,230

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
13.66%
3M shares short
Days to cover
7.0
At 0M shares a day
Change since last report
+4.7%
From 3M shares
Short volume, 20 days
27.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tiziana Life Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 16,079 shares on Sep 11, 2026 over the last 90 days.

See a number that looks wrong?